Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Clinical and Experimental Vaccine Research ; : 121-129, 2015.
Artigo em Inglês | WPRIM | ID: wpr-37507

RESUMO

The use of pneumococcal vaccine plays an important role for prevention of invasive pneumococcal disease (IPD). However, introducing the pneumococcal vaccine into the national immunization program (NIP) is complex and costly. The strategy of progressively integrating the pneumococcal conjugate vaccine (PCV) into the NIP in Taiwan provides valuable experience for policy makers. The 7-valent PCV (PCV7) was first available in Taiwan in late 2005. PCV7 was first provided free to children with underlying diseases, those in vulnerable socioeconomic status, and those with inadequate health care resources. The catch-up immunization program with the 13-valent PCV was launched in 2013 and the national pneumococcal immunization program was implemented in 2015. Children aged 2-5 years had the highest incidence of IPD among pediatric population in Taiwan. Although the incidence of IPD caused by PCV7 serotypes has declined, the overall incidence of IPD remained high in the context of PCV7 use in the private sector. A surge of IPD caused by serotype 19A occurred, accounting for 53.6% of IPD cases among children aged < or = 5 years in 2011-2012. After the implementation of the national pneumococcal immunization program, serogroup 15 has become the leading serogroup for IPD in children. Continued surveillance is necessary to monitor the serotype epidemiology in Taiwan.


Assuntos
Criança , Humanos , Pessoal Administrativo , Atenção à Saúde , Epidemiologia , Programas de Imunização , Incidência , Vacinas Pneumocócicas , Setor Privado , Classe Social , Taiwan
2.
Annals of the Academy of Medicine, Singapore ; : 333-333, 2010.
Artigo em Inglês | WPRIM | ID: wpr-234146

RESUMO

Children, especially those younger than 5 years of age and those with chronic medical conditions, such as respiratory diseases, neurological diseases, immunosuppression, receiving longterm aspirin therapy, obesity or co-infection with bacteria, are at an increased risk of pandemic H1N1 infection-related complications. This paper reviews the underlying medical conditions associated with death or complications of pandemic H1N1 infection in children.


Assuntos
Adolescente , Criança , Pré-Escolar , Humanos , Doença Crônica , Comorbidade , Hospedeiro Imunocomprometido , Vírus da Influenza A Subtipo H1N1 , Influenza Humana , Epidemiologia , Mortalidade , Doenças do Sistema Nervoso , Obesidade , Pediatria , Sistema Respiratório , Fatores de Risco
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA